Navigation Links
Roches Arthritis Drug Successful in III Stage Trail

Roche Holding AG says that arthritis drug Actemra has proved successful in a phase III clinical study. Actemra helps relieve symptoms of rheumatoid arthritis in difficult-to-treat patients in a clinical study thus bringing it closer to regulatory approval.

The Radiate study was conducted over 24 weeks with 498 patients with difficult-to-treat RA. Actemra was given in combination with a standard treatment called methotrexate in patients who had an inadequate response to a relatively new type of drugs known as anti-tumor necrosis factor therapy, or anti-TNFs. The treatment showed a significant improvement in disease signs and symptoms.

Biologic Actemra (tocilizumab), a humanized monoclonal antibody works by a different mechanism than today's rheumatoid arthritis treatments. Actema is the first biologic to inhibit the interleukin-6, or Il-6, receptor. IL-6 is considered an important mediator of the acute inflammatory response.

Sufferers of rheumatoid arthritis, or RA, begin to experience progressive joint damage early in the disease. The disease differs from what is popularly known as arthritis, typically associated with age-related joint pain; RA is a far more serious inflammatory disease that leads to destruction of cartilage and bone, and can lead to disability.

Roche plans to file Actemra, developed by Japanese pharmaceutical company Chugai Pharmaceutical Co. which Roche controls, for regulatory approval in Europe and the U.S. by the end of 2007.

This is the third of five international late-stage trials that are investigating Actemra's efficacy and safety. Roche plans to release results from one more this year, while data from the fifth study will become available at a later date.


'"/>




Page: 1

Related medicine news :

1. Distinguished Scientist Award Conferred on University of Rochester Scientists for Work on Preventing Cavities
2. Another ray of hope for Arthritis Sufferers
3. Naked DNA Vaccination May Conquer Arthritis and Multiple Sclerosis
4. B Vitamin protects and lowers toxicity of Arthritis Drug
5. FDA Approves New Arthritis Drug, Bextra
6. Risk Of Developing Arthritis
7. Arthritis Drug May Cause Liver Damage
8. Arthritis drug can prolong life
9. New treatment for Rheumatoid Arthritis
10. Important cause of Arthritis
11. Personality Impacts Arthritis

Post Your Comments:
(Date:12/1/2009)... 1 With employee benefit...f employers are providing self-service decision-ma...n, according to a new survey by Watson Wyatt, a le...ers who offer these tools believe they lead employ... According to the survey, 45 percent of companies ...
(Date:12/1/2009)...Dec. 1 On December 31, ...federal prisoners were HIV positive or had confirm... the Office of Justice Programs, U.S. Department o...timated 5,672 inmates in state and federal prisons...007, about 43 per 10,000 prison inmates were estim...
(Date:12/1/2009)... and South America, study finds , , TUES...f intensive care unit patients worldwide suffer in...e hospital, a new study finds. , Researchers an...) on 13,796 patients, aged 18 and older, in 1,265 ...f patients were classified as infected and 71 perc...
(Date:12/1/2009)...2009) Wistar Institute researchers and collaborat...rk University have identified immune system marker...ors in people at high risk for developing lung can... Cancer Research , a journal of the American Assoc... blood test to detect lung cancer in its earliest ...
(Date:12/1/2009)...GLE PARK, N.C., Dec. 1 Max Neeman ...expanded over the years serving the top most pharm...as originally set up in an area of 2000 sq. ft. ha...of the suite of services by Max Neeman, are recogn...ffering. ,, The pharmacy inventory management p...
Breaking Medicine News(10 mins):Health News:Employers Plan to Increase Use of Self-Service Decision-Making Technology For Open Enrollment, Watson Wyatt Survey Finds 2Health News:Employers Plan to Increase Use of Self-Service Decision-Making Technology For Open Enrollment, Watson Wyatt Survey Finds 3Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 2Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 3Health News:Half of ICU Patients Suffer From Infections 2Health News:Wistar-led research team discovers genetic pattern that indicates early-stage lung cancer 2Health News:Wistar-led research team discovers genetic pattern that indicates early-stage lung cancer 3
...their rich color from lycopene, a disease-fighting...a special variety of orange-colored tomatoes provi...dies may more readily use. Researchers found ...in participants' blood. “While red tomatoes...
...ledge are great healers and 140 French psychiatris...study this value system. // "The Indian val...dealing with mental health issues and we are here ... to tackle it. India is a huge country and its tra...
...m holes in their eardrums could have better succes... doctors at West Virginia University. // The ... Otolaryngology – Head and Neck Surgery, the offic...study measured success rates of patching eardrum h...
...regnant should opt for ice creams and whole milk i...tudy undertook by Jorge Chavarro and colleagues// .... This study was conducted in the United Stat...ee milk may prove counter productive for women who...
...bsite Netmums, has the outcome that a majority of ... and understandable//, especially when in a hurry ...0 persons interviewed supported the ‘traffic light...each color signifies an amount. For example, red s...
...the Methodist DeBakey Heart Center in Houston show...lesterol by an unprecedented// 70 percent, and has...flammation that can lead to heart disease and stro...for inflammation, in patients treated with 40 mg o...
Other Medicine News:Health News:Unique Tomatoes Tops In Disease-Fighting Antioxidants 2Health News:Unique Tomatoes Tops In Disease-Fighting Antioxidants 3Health News:Inner-ear Volume Study Leads to Higher Surgery Success Rates 2Health News:Mothers Gives ‘thumbs Up’ for Traffic Light Labeli 2Health News:Statin Therapy Cuts Bad Cholesterol Unprecedented 70 Percent 2
(Date:12/1/2009)...c. 1 CCS Medical, Inc. a leading d...day announced that it has received approval from t...Delaware (the "Court") for its bidding procedures ... of substantially all of its assets. ,, Pursuan...pproved bidding procedures for the sale of substan...
(Date:12/1/2009)...PRNewswire-FirstCall/ -- WebMD Health Corp. (Nasda...on, today announced the honorees of the 2009 WebMD...lth Heroes honor Americans with extraordinary stor... an effort to help others achieve better health. ...prnh/20091201/NY18114 ) ,, "WebMD is honoring ...
(Date:12/1/2009)..., Dec. 1 nContact Surgical, Inc. (...ces for minimally-invasive treatment for heart con...bility clinical trial designed to evaluate the saf...er procedure, the convergent procedure, for the tr...ion (AF). This prospective, feasibility study wil...
Breaking Medicine Technology:CCS Medical Wins Approval from Bankruptcy Court for Its Chapter 11 Asset Sale Bidding Procedures 2WebMD Announces 2009 Health Heroes 2WebMD Announces 2009 Health Heroes 3nContact Announces Initiation of Clinical Trials for the Treatment of Paroxysmal Atrial Fibrillation Utilizing New Convergent Ablation Procedure 2Cobb Pediatric Therapy Services Joins Forces with Travis Consulting LLC to Offer Expanded Services Across the U S 57905 1Cobb Pediatric Therapy Services Joins Forces with Travis Consulting LLC to Offer Expanded Services Across the U S 57905 2Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 1Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 2Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 3Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 4Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 5Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 6Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 7Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 8Clinton Global Initiative 3A September 22 25 2009 3A Health Care Access and Quality Improves For Millions in Rwanda and Haiti Due to Innovative Perfo 57899 1Clinton Global Initiative 3A September 22 25 2009 3A Health Care Access and Quality Improves For Millions in Rwanda and Haiti Due to Innovative Perfo 57899 2Clinton Global Initiative 3A September 22 25 2009 3A Health Care Access and Quality Improves For Millions in Rwanda and Haiti Due to Innovative Perfo 57899 3
...d in Third Quarter -, SAN FRANCISCO, March 20 VI...y company focused on the development of,compounds ...nced today that,it has completed patient enrollmen...irst of three Phase 2 trials investigating VIA-229...1 is a potent small molecule drug that targets inf...
... not the Only Way We Suffer - Allerg...N.J. and WHITEHOUSE STATION, N.J., March 20, Indoo...ople in the United States.(1)(2) Yet, according to... survey, allergies are often,disregarded as a nuis...ect.,As a result, allergy sufferers continue to co...
Other Medicine Technology:VIA Pharmaceuticals Completes Enrollment In Phase 2 Carotid Endarterectomy (CEA) Trial 2VIA Pharmaceuticals Completes Enrollment In Phase 2 Carotid Endarterectomy (CEA) Trial 3VIA Pharmaceuticals Completes Enrollment In Phase 2 Carotid Endarterectomy (CEA) Trial 4VIA Pharmaceuticals Completes Enrollment In Phase 2 Carotid Endarterectomy (CEA) Trial 5New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 2New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 3New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 4New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 5New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 6New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 7
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
Medicine Products: